Pfizer's Upjohn has merged with Mylan to form Viatris Inc. × Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. epilepsy: 3 indexed trials, 0 recruiting studies across 3 countries in the current NeuroRisk corpus.
Request comparative brief →Indexed trials3
Recruiting0
Countries3
Indexed studies
NCT00280059Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
BelgiumPHASE3
BelgiumPHASE3
NCT00372528An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures
CanadaPHASE3
CanadaPHASE3
NCT00785772A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment
JapanPHASE4
JapanPHASE4
Enterprise comparison
Compare sponsor momentum, recruiting activity, geography and connected evidence with the broader NeuroRisk intelligence layer.
Request enterprise access →